Clinical trial No longer in our active list Observational Ages 18 and up

Tool for screening and diagnosing lower limb lymphedema in cancer patients

Official title: Development of a Clinical Screening, Diagnostic and Evaluation Tool for Patients With Lower Limb Lymphedema: Development of a Screening Set for Patients at Risk for Developing LLL

Run by KU Leuven · NCT05421377 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is trying to create a new tool to help doctors spot and diagnose lower limb lymphedema in cancer patients, especially those who have had certain types of cancer surgeries.

More Lymphedema, Lower Limb trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment120 (estimated)
SponsorKU Leuven
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Leuven)
Trial IDNCT05421377 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients diagnosed with skin melanoma (stage 3 or higher), gynecological cancer, or urogenital cancer who are scheduled for surgery involving lymph node dissection.

Probably not a fit

Patients who are pregnant or have chronic venous insufficiency, deep venous thrombosis, or active skin infections on the lower limbs will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to develop a clinical screening, diagnostic, and evaluation tool specifically for patients suffering from lower limb lymphedema, particularly those with a history of skin melanoma, gynecological cancer, or urogenital cancer. The study focuses on patients who are undergoing surgical procedures that may increase their risk of developing lymphedema, such as lymph node dissection. By assessing various risk factors and clinical parameters, the study seeks to improve early detection and management of this chronic condition. The findings could lead to better patient outcomes and quality of life for cancer survivors.

Why it matters

Potential benefit: If successful, this tool could significantly enhance the early detection and management of lower limb lymphedema, improving the quality of life for affected patients.

How similar studies have gone: While there may be studies focusing on lymphedema management, this specific approach to developing a comprehensive screening and diagnostic tool appears to be novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with a diagnosis of skin melanoma (at the level of the lower limb, at least cancer stage 3), gynecological cancer, uro-genital cancer that will receive surgery (sentinel lymph node biopsy and/or (para-aortic/inguinal/pelvic) lymph node dissection)

Exclusion Criteria:

* Pregnant participants
* Presence of chronic venous insufficiency C4, C5, C6; deep venous thrombosis; post-thrombotic syndrome
* Presence of skin infections of wounds at the level of the lower limbs at the moment of inclusion

Where it's running

  • University Hospitals of Leuven
    Leuven, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.